- Diabetes accelerates reduced lung capacity By : Health News
A new study has cited that people with diabetes experience a faster loss of lung capacity as compared to those who do not have the disease......... - ArthroCare(R) Sports Medicine To Tackle Diabetic Foot Ulcers By : Health News
As part of ArthroCare Sports Medicine's recent entry into the Foot and Ankle arena......... - Sweet Results For Diabetes From A Ton Of Bitter Melon By : Health News
Scientists have uncovered the therapeutic properties of bitter melon, a vegetable and traditional Chinese medicine, that make it a powerful treatment for Type 2 diabetes. - Elixir Announces Completion Of Enrollment In Pivotal Phase III Clinical Trial For New Diabetes Drug By : Health News
Elixir Pharmaceuticals, Inc., announced that it has completed enrollment in its final pivotal phase III clinical study of mitiglinide for the treatment of patients with type 2 diabetes. - Metabolex Initiates Phase 1 Trial Of MBX-2982 By : Health News
Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases............ - Reduced Lung Capacity Accelerates With Diabetes By : Health News
People who have diabetes encounter a faster loss of lung capacity than those who do not have diabetes......... - Reduced Lung Capacity Accelerates With Diabetes By : Health News
People who have diabetes encounter a faster loss of lung capacity than those who do not have diabetes.......... - Revised: Challenging The Norm May Lead To New Therapy For Type 2 Diabetes By : Health News
What happens when leading biochemists get together to challenge conventional pharmaceutical theories? Often, incredible new drug therapies are born. - DSMB Again Supports Continuation Of The Phase III Clinical Trial Of Medidur(TM) FA For The Treatment By : Health News
After completing its review of safety and efficacy data currently available, an independent Data Safety Monitoring Board (DSMB) has once again recommended that the two pivotal Phase III clinical trials........... - Challenging The Norm May Lead To New Therapy For Type 2 Diabetes By : Health News
What happens when leading biochemists get together to challenge conventional pharmaceutical theories? Often, incredible new drug therapies are born. - Cedars-Sinai Seeks Participants With Type 2 Diabetes For Study Of Implantable Devices By : Health News
Cedars-Sinai Medical Center is seeking participants with type 2 diabetes for a randomized........... - Alarming Facts About Diabetes: This Growing Epidemy By : Marco Polytzo
Diabetes is a serious disease. But the startling truth is that diabetes is reversible. Diabetes is the number one cause of chronic kidney disease (CKD). - Diabetes Treatment And Info: All You Need To Know By : Marco Polytzo
Diabetes is a critical health care problem for many people throughout the world. It decreases quality of life and, in many cases, it can also shorten one's life. - All About Diabetes: Symptoms, Causes, Types. By : Marco Polytzo
Diabetes is a serious disease. But the startling truth is that diabetes is reversible. Diabetes is the number one cause of chronic kidney disease (CKD).Recognizing diabetes symptoms can help you to prevent further devastating diabetes complications. Or, if you are a person in risk for developing diabetes, this can help you to prevent the diabetes onset. Anyway, keep in mind that you may not have all the symptoms of diabetes, maybe just only one diabetes symptom. - Akesis Pharmaceuticals Doses First Patient In Phase IIa Trial Of AKP-020 For Type 2 Diabetes By : Health News
Akesis Pharmaceuticals, Inc. an emerging diabetes drug-development company........... - 3.4 Million Dollars Award To Study Internet Coping Skills For Diabetic Children By : Health News
The National Institute of Nursing Research has awarded Yale University School of Nursing (YSN) 3.4 million dollars to compare the effectiveness of Internet-based coping skills training versus an Internet education program for diabetic children. - Tips For Troublesome Medications, From The Harvard Heart Letter By : Health News
Bad reactions to a prescribed medication send more than 175,000 older Americans to the emergency room each year. - Associated Foot & Ankle Specialists Enrolling Patients With Chronic Diabetic Foot Ulcers By : Health News
Associated Foot & Ankle Specialists announced it is recruiting patients with foot ulcers due to diabetes to participate in the MATRIX clinical trial. - InteKrin Therapeutics Announces Initiation Of Phase 2b Study In Type 2 Diabetes With INT131 By : Health News
InteKrin Therapeutics, Inc., a privately-held clinical stage biopharmaceutical company focused on the development and commercialization of novel drugs for the treatment of diabetes........... - Researchers Pursue Multiple Approaches To Type 1 Diabetes By : Health News
Type 1 diabetes, formerly called insulin-dependent diabetes, juvenile diabetes or childhood onset diabetes, affects 1 to 2 million people in the U.S. and millions more worldwide. - Test For Blood Sugar Not Accurate In Diabetic Dialysis Patients By : Health News
The standard test for measuring blood sugar control in people with diabetes is not accurate in those on kidney hemodialysis, according to new research at Wake Forest University Baptist Medical Center. - Safety Medical Products (ASX:SFP) Announce Supply Of Retractable Syringes To The National Diabetes By : Health News
In an Australian first, people with diabetes will soon have free access to retractable syringes supplied through the National Diabetes Services Scheme (NDSS). - Stress Hormone Impacts Memory, Learning In Diabetic Rodents By : Health News
Diabetes is known to impair the cognitive health of people, but now scientists have identified one potential mechanism underlying these learning and memory problems. - Hispanics Have More Difficulty Controlling Diabetes Than Non Hispanic Whites By : Health News
Results of an analysis of multiple studies show diabetes control is more challenging for Hispanics than non-Hispanic whites, according to researchers at Wake Forest University Baptist Medical Center and colleagues. - Statement From The American Diabetes Association Related To The ADVANCE Study Announcement By : Health News
Investigators in the ADVANCE Study, an international study involving 11,140 high-risk patients with type 2 diabetes, announced that their study provides no evidence of an increased risk of death among those patients receiving intensive treatment to lower blood glucose (sugar). - Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial By : Health News
Keryx Biopharmaceuticals announced that the last subject randomized into the SUN-Micro Phase 3 clinical trial has completed their scheduled 8 month visit. - Government To Fund Islet Cell Transplants, UK By : Health News
A treatment, developed thanks to Diabetes UK-funded research, that offers hope for some people with Type 1 diabetes who suffer from the most serious effects of hypoglycaemia will be made available on the NHS. - Pharmacist-Run Diabetes Program Gets Funding Boost By : Health News
The Bank of America Foundation's recent awarding of a $250,000 grant to support the El Rio Community Health Center's pharmacy-based diabetes management program is the latest acknowledgment of the Tucson, Arizona, program's success. - Statement From The American Diabetes Association Related To ACCORD Trial Announcement By : Health News
In response to today's announcement by the National Heart, Lung, and Blood Institute, which sponsors the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Trial to stop the intensive blood glucose (sugar) control sub-study in ACCORD due to safety concerns.......... - Diabetech® Launches GlucoMON®-RT Real-Time Monitoring for Remote Diabetes Caregivers By : Health News
As the result of over 5 years of development in over a dozen clinical trials conducted throughout the USA, Diabetech is pleased to announce the direct-to-consumer commercial availability of the GlucoMON-RT subscription service for delivering real-time blood glucose alerts to remote caregivers as well as automated reporting. - Aung FootHealth Clinics & Advanced Wound Care Center Enrolling Patients With Chronic Diabetic By : Health News
Aung FootHealth Clinics & Advanced Wound Care Center announced it is recruiting patients with lower extremity diabetic foot ulcers to participate in the MATRIX clinical trial. - Randox Introduces A Range Of 25 Liquid And Ready-To-Use Protein Assays By : Health News
Randox have introduced a range of 25 liquid and ready-to-use protein assays. Clinicians use protein assays to diagnose and monitor a diverse range of diseases and conditions such as diabetes, arthritis and anaemia. - Medtronic Announces FDA Approval Of CGMS(R) IPRO(TM) Continuous Glucose Recorder By : Health News
Medtronic, Inc. announced the FDA approval of a new physician-use continuous glucose monitoring (CGM) system, the CGMS® iPro™ Recorder. - Hidden Dangers of Soy: Soy Product Dangers By : WEBNOX
The Hidden Dangers Of Soy, Soy Protein Dangers, Dianne Gregg, studies about the dangers of soy facts to those people who believe that soy is healthy, my personal story, severe allergy, health and wellness book, dangers of soy, soy protein dangers, soy milk danger, soy product dangers, soy infant formula, isoflavone, thyroid disease, cancer, menopause, Osteoporosis - Encouraging Results Spur PhytoMedical’s Continued Development of Diabetes Compound by Way of New By : Diabetes News
PhytoMedical Technologies, Inc. (OTCBB:PYTO) (FWB:ET6) today announced plans to initiate a dose escalation study for the company’s compounds for type-2 diabetes, following successful completion of earlier studies of the same compounds, evaluating their viability and important diabetes-related activity....... - Green Tea Diet Pills Jump-Start Your Fat-Burning and Diabeties Fighting Ability... By : P. Rodgers
Green tea diet pills are a good way in which you can educe your weight. It seems that each study yields more benefits of the green tea diet. Diabetes and excess weight are very closely related; the risk of diabetes increases with weight gain. If you want to jump-start your fat-burning ability, then Green Tea Diet is the product for you. - VeriChip Corporation to Attend Philadelphia Diabetes EXPO and Offer VeriMed Patient Identification By : Health News
VeriChip Corporation (NASDAQ:CHIP), a provider of RFID systems for healthcare and patient-related needs, announced today it will attend the Philadelphia Diabetes EXPO on November 17, 2007, at the Pennsylvania Convention Center from 10:00 a.m. to 4.00 p.m. The Philadelphia Diabetes EXPO is sponsored by the American Diabetes Association (ADA)..... - Crocs Rx™: A Prescription for Your Feet By : Health News
According to the American Diabetes Association, nearly seven percent of the U.S. population is suffering from diabetes. Crocs Rx™, the medical division of Crocs, Inc. (NASDAQ: CROX), today announced the American Podiatric Medical Association (APMA) has awarded the entire Crocs Rx™ line its Seal of Acceptance based on a myriad of podiatric standards...... - Wheaton Franciscan Medical Group in Wisconsin to Partner with International Diabetes Center and By : Health News
UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, is partnering with International Diabetes Center at Park Nicollet (IDC) to implement IDC’s evidence-based education and treatment program, Diabetes Connections, at Wheaton Franciscan Medical Group throughout Southeastern Wisconsin...... - Tweens Double Use of Diabetes Drugs By : Health News
America’s tweens more than doubled their use of type-2 diabetes medications between 2002 and 2005, with girls between 10 and 14 years of age showing a 166 percent increase. The likely cause: Obesity, which is closely associated with Type 2 diabetes...... - Diabetes Incidence and Costs on the Rise in Gordian Study By : Health News
A recent study released by Gordian Health Solutions, a leading national health and productivity improvement company, shows that employer-paid diagnosed (non-pharmaceutical) medical costs for diabetes continue to rise significantly—as much as a 64 percent increase in just five years.. - Toshiba Introduces FaCTor64 Study to Improve Early Diagnosis and Treatment of Coronary Artery By : Health News
Toshiba America Medical Systems, Inc. today announced faCTor64, the Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following CorE 64: A Randomized Control Study....... - Walgreens Celebrates 6,000 Stores Nationwide with Grand Opening in New Orleans By : Health News
Walgreens (NYSE:WAG)(NASDAQ:WAG), the nation’s largest drugstore chain, is hosting a special event today to mark the grand opening of its 6,000th store nationwide in New Orleans. State and local officials will welcome the familiar retailer to another New Orleans community during a ribbon cutting ceremony at 9 a.m..... - MicroCHIPS Hires Industry Veteran Robert Farra to Lead Diabetes and Drug Delivery Product Programs By : Health News
MicroCHIPS, Inc., an innovative developer of biosensing and drug delivery devices, today announced Robert Farra has joined the company as Vice President of Research and Development. Mr. Farra is charged with leading the company’s drug delivery and diabetes monitoring programs through preclinical and clinical development....... - Ancient Healing Power: Honey Makes Sweet Comeback in Treating Advanced Wounds By : Health News
MEDIHONEY™ Wound & Burn Dressings are being distributed this month to physicians, hospitals and acute rehabilitation clinics. The product marks the first FDA clearance of a honey-based product for managing wounds and burns..... - Diabetes Rates Are Increasing Among Youth By : Health News
While most children and young adults with diabetes have type 1, soaring obesity rates are making type 2 diabetes, a disease that used to be seen primarily in adults over age 45, more common among young people. - London Eye Lights Up For World Diabetes Day By : Health News
The London Eye was lit up in blue last Friday to mark the beginning of celebrations of the first UN-observed World Diabetes Day, on Wednesday 14 November. - DSMB Supports Continuation of the Phase III Clinical Trial of Medidur™ FA for the Treatment of DME By : Health News
After completing its review of safety and efficacy data currently available, an independent Data Safety Monitoring Board (DSMB) has recommended that the pivotal Phase III clinical trial FAME™ (Fluocinolone Acetonide in Diabetic Macular Edema) Study continue under the current protocol, without change. The trial is studying the use of Medidur FA for the treatment of diabetic macular edema (DME).... - Fenofibrate Lessens Need For Laser Treatment For Diabetic Retinopathy By : Health News
Patients with Type 2 Diabetes who are treated with fenofibrate do not require laser treatment for diabetic retinopathy (DR) as often as similar patients who do not receive fenofibrate, according to an article in The Lancet. - FDA Approves Supplemental New Drug Applications for JANUVIA™ (sitagliptin) By : Health News
Merck & Co., Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved expanded labeling for JANUVIA™ (sitagliptin), the only DPP-4 inhibitor available in the United States for the treatment of type 2 diabetes. JANUVIA is indicated, as an adjunct to diet and exercise, to improve glycemic control in adult patients with type 2 diabetes...... - Illumina Announces Multi-Million Dollar Agreement with the University of Virginia and the National By : Health News
Illumina, Inc. (NASDAQ:ILMN) announced today that it has agreed to process more than 6,500 samples for researchers of the Type 1 Diabetes Genetics Consortium (T1DGC) via its FastTrack Genotyping Services. With financial support from the NIDDK, the T1DGC will attempt to identify genes that influence an individual’s risk for developing type 1 diabetes...... - NIH to Sponsor Preclinical Study of DiaKine Diabetes Drug By : Health News
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a section of the National Institutes of Health (NIH), will sponsor preclinical testing of a new oral drug being developed by DiaKine Therapeutics that may prevent or reverse diabetes...... - NuVim Debuts New Shelf Stable Beverage at the 2007 American Dietetic Association Convention By : Health News
NuVim, Inc. (OTCBB:NUVM), a leading provider of dietary supplements, recently debuted its new shelf stable beverage at the 2007 American Dietetic Association (ADA) Food and Nutrition Conference. All three varieties -- Orange Tangerine, Strawberry Vanilla and Fruit Symphony -- were sampled at the convention and free coupons provided to encourage usage at home and trial with the dietitians and their patients..... - Diamaxol By : Curtis McCoy
Diamaxol is a propriety drug marketed and developed by MicroNutra Health incorporated. Diamaxol is designed to regulate blood sugar levels in people suffering from diabetes. Diamaxol is also believed to facilitate cell growth, increase insulin production, and is a mixture of natural extracts and essential minerals like zinc and chromium. Since Diamaxol is made from natural extracts it is easily absorbed by the body and compared to traditional medicines (that are designed to replace hormones like Insulin), Diamaxol controls diabetes by encouraging insulin synthesis and regulating blood sugar levels. To better understand the potential of Diamaxol, below is a list of the ingredients included in Diamaxol: - Largest Diabetes Audit Reveals Gaps In Paediatric Care, UK By : Health News
Diabetes UK expressed concern that 83 per cent of children and young people with diabetes are not achieving recommended blood glucose levels, according to the biggest audit of diabetes care in the world. - Diabetes Drug To Be Developed By EpiVax With JDRF Program Funding By : Health News
EpiVax, Inc, a leader in the field of computational immunology, has announced that it has received funding from the Juvenile Diabetes Research Foundation (JDRF).......... - Aggressively Treating Cardiac Risk Factors May Reverse Ischemia By : Health News
People with diabetes who have asymptomatic heart disease may be able to vastly improve the flow of blood to their hearts without surgical intervention, according to a study being published in the November issue of Diabetes Care, which comes out on October 26, 2007. - Healthways Supports Southwest General to Become First Hospital in Texas Granted the Joint Commiss By : Health News
Southwest General Hospital, partnering with Healthways Hospital Diabetes Service, is the first hospital in Texas, and the third in the United States, to earn a Certificate of Distinction for Advanced Inpatient Diabetes Care from The Joint Commission, the national organization accrediting healthcare organizations across the country..... - Rising Rates Of Diabetes Highlighted, UK By : Health News
Rising rates of diabetes have been identified as a particular challenge to the health of people across England. - Get Thin For Life By : Evano Walraven
Are you searching for a quick weight loss program? Look no further.
With Get Thin For Life you will be certain quick weight loss. - Blood Bank of Delmarva Launches the First Diabetes Testing Program for Blood Donors By : Health News
It had taken months of hard work and planning, but Stuart Sherman and his wife Melissa had finally taken their family of four on their dream vacation to Disneyworld. An athlete, non-profit executive and active dad in his 30s, Sherman was looking forward to a week of fun and laughter with his young children.... - Mothers With Diabetes Parted From Newborns, UK By : Health News
Mothers with diabetes are being separated from their newborn babies, according to findings out. - European Medicines Agency Confirms Positive Benefit-Risk Balance For Rosiglitazone And Pioglitazone By : Health News
Finalising a review of the benefits and risks of the thiazolidinediones rosiglitazone (Avandia) and pioglitazone (Actos), the European Medicines Agency has concluded that the benefits of these antidiabetic medicines continue to outweigh their risks in the approved indications. - Diabetes Epidemic Addressed in Exclusive Series for ReZoom.com By : Health News
Nationally recognized diabetes expert, Francine R. Kaufman, M.D. is writing a series of articles on how diabetes is a growing epidemic among adults past 40 for ReZoom.com..... - Facts About Type 2 Diabetes Cure By : Andy Rowde
Are you looking for reliable type 2 diabetes cure data? Do you have questions about type 2 diabetes cure that you need answers to? Find out the truth about type 2 diabetes cure. - Rite Aid Joins American Diabetes Association in Special Diabetes Awareness Promotion Oct, Nov, Dec By : Health News
According to the American Diabetes Association (ADA), nearly 21 million children and adults in the United States have diabetes. While an estimated 14.6 million have been diagnosed, unfortunately, 6.2 million of them don’t even know that they have the disease! To fight the growing epidemic and educate its patients, Rite Aid (NYSE:RAD), will offer a free 18-page Diabetes Guide and a Diabetes Tip Booklet in all stores during October, November and December........ - Diamyd Medical: US National Institutes of Health Announces Plans to Sponsor a Type 1 Diabetes Trial By : Health News
Diamyd Medical (STO:DMYDY) announced today that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has posted a planned international clinical study with the Diamyd® GAD-alum diabetes vaccine in 126 new onset type 1 diabetes patients on the NIH clinical trials webpage, www.clinicaltrials.gov. The study is proposed by the NIH/NIDDK sponsored global network TrialNet, a group of the world’s foremost experts and key opinion leaders in type 1 diabetes. - Diamyd Medical: Diamyd® Diabetes Vaccine Effective for at Least 21 Months By : Health News
Diamyd Medical announced today that the statistically significant protective effect of the experimental Diamyd® vaccine on insulin secretion in type 1 diabetes patients remains still 21 months after the first injection..... - Advances In Drug Discovery Technologies Fuelling Development of Anti-Diabetic Therapies By : Health News
Rising knowledge of metabolic pathways at genetic, cellular, and molecular levels is giving rise to more focused molecular drug targets. This, coupled with significant advances in drug discovery technologies, is rekindling interest in the immense potential of therapeutic diabetes drugs, resulting in a multiplicity of pharmaceutical drug targets. - Why Angioprim was invented By : Thomas Snee SR.
Do you have any of the following symptoms: Night Cramp in hands or feet? Fingers or toes that often feel cold? Your arms or legs often "go to sleep"? Is there a diagonal crease in your earlobe? Do you experience numbness in the arms or legs? A whitish ring under the outer cornea in your eye? Do your lips or fingers often have a tingling sensation? Breathless with slight exertion or when lying down? On short walks, do your legs get aches or pains? Is your memory worse than it used to be? Ankles that swell late in the day? Has your blood pressure increased lately? If you answered yes to even one of these questions, you may have early warning signs of arterial blockages. - New Data Support Long-Term Efficacy and Safety in Patients Who Took Exubera for Eight Years By : Health News
Two new studies presented today at the European Association for the Study of Diabetes (EASD) meeting reinforce the efficacy and safety of Exubera (insulin human [rDNA origin]) Inhalation Powder for adults with diabetes. - Diamyd Medical: Further Evidence for Lasting Immunological Efficacy of Diamyd Diabetes Vaccine By : Health News
Diamyd Medical (NASDAQ:DMYDY) (STO:DIAMB) announced today that further evidence for lasting immunologic efficacy of the Diamyd® diabetes vaccine, was presented at the European Association for the Study of Diabetes (EASD) conference in Amsterdam on the 18th of September 2007. The presentation confirmed that treatment with Diamyd® causes a specific immune response to GAD65 remaining even 15 months after treatment. The immunological effect was observed in patients receiving Diamyd®, but not in.... - JDRF Partners with CoMentis for Diabetic Macular Edema Clinical Trial By : Health News
The Juvenile Diabetes Research Foundation, the world's largest charitable funder of type 1 diabetes research, today announced a partnership with CoMentis, Inc. to support the biotechnology company’s human clinical trial of ATG3, a topical eye drop therapy for diabetic macular edema...... - University Of South Florida Awarded $169 Million For International Juvenile Diabetes Study By : Health News
The National Institutes of Health has awarded $169 million to the University of South Florida to coordinate and analyze results from a 10-year international study to determine the environmental causes of juvenile diabetes. - Oculus Innovative Sciences to Conduct Conference Call Update on Phase II Study of Microcyn® Technol By : Health News
Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) today announced that President and CEO Hoji Alimi will hold a conference call on Monday, September 17, 2007 at 9:00 a.m. (EDT) to update investors on recent progress in the ongoing, open-label Phase II clinical trial of the company’s flagship product manufactured using Microcyn®.... - Kmart Steps Out To Fight Diabetes By : Health News
The American Diabetes Association (ADA) announced that Kmart has reinforced its commitment to ADA and elevated its support for the diabetes community by becoming a National Strategic Partner (NSP). - Phenomix Initiates Phase 2b Clinical Trial of PHX1149 for Type 2 Diabetes; Will Present PHX1149 Data By : Health News
Phenomix Corporation, a drug discovery and development company, announced today the initiation of a Phase 2b clinical trial of PHX1149, an internally-discovered product candidate for the treatment of Type 2 diabetes. The trial is being conducted at multiple sites worldwide.. - Diabetes May Result From Botched Production Of Insulin Molecule By : Health News
Picture a pretzel factory production line, with conveyer belts carrying the dough, formed into unbaked pretzels, down to the oven to be cooked. - Type 2 Diabetes Patients More Likely To Develop Congestive Heart Failure When Given Rosiglitazone By : Health News
A patient with Diabetes Type 2 (or prediabetes) is more likely to have congestive heart failure (CHF) when receiving rosiglitazone or pioglitazone, but his/her risk of cardiovascular death (CVD) is not raised. - Type 2 Diabetes Patients More Likely To Develop Congestive Heart Failure When Given Rosiglitazone By : Health News
A patient with Diabetes Type 2 (or prediabetes) is more likely to have congestive heart failure (CHF) when receiving rosiglitazone or pioglitazone, but his/her risk of cardiovascular death (CVD) is not raised. - NationsHealth Acquires Diabetes Care & Education, Inc. By : Health News
NationsHealth, Inc. (Nasdaq: NHRX) today announced that it has acquired Diabetes Care & Education, Inc. (DC&E), a leading provider of insulin pumps, pump supplies and blood glucose monitoring equipment.. - PhytoMedical Releases Preliminary Research Results For New Class of Diabetes Compounds By : Health News
PhytoMedical Technologies, Inc. (OTCBB:PYTO) (FWB:ET6), today announced preliminary results from recent low-dosage animal studies of the Company’s compounds for type-2 diabetes. The compounds being tested are synthetic versions of the isolated active metabolite derived from cinnamon and potentially represent an entirely new class of compounds for the treatment of type-2 diabetes..... - In Memoriam: Steve Byars By : Health News
Everyone at Axerra Networks regarded Steve Byars not only as a hard-working colleague and talented marketing executive, but also as a valued friend. It is for this reason that his sudden death from a diabetes-related complication at age 50 is so sincerely mourned by all...... - Complications of Diabetes By : John Richmond
A major part of diabetes treatment involves the prevention of complications. Diabetes can cause serious damage to the cardiovascular system, eyes, and kidneys. The earlier the disease can be diagnosed the better because oftentimes the damage is occurring and the person isn't even aware of it. - Stop Guessing If You Have Type 2 Diabetes. Learn Its Symptoms Now By : James Troy
Type 2 diabetes, which was previously also known as Non-Insulin Dependent Diabetes, tend to have its symptoms develop rather slowly and gradually. Usually it takes around a few weeks to a few months for these type 2 diabetes symptoms to show. Sufferers of type 2 diabetes are more prone to illnesses like kidney damage, eye failure, heart disease, and heart stroke. - Doctors and Nutritionist say..... you need more calcium. But Wait By : Thomas Snee SR.
No matter your age or health condition, you can extend your life and add life to your years beginning right now! You can improve your overall health & vitality, and increase your energy levels. You can truly look & feel younger than your years. Angioprim can help promote a healthy cardiovascular system. - Type 1 Diabetes Destroying Your Life? Don't Let That Happen. By : James Troy
Type 1 diabetes may also be known by some other names such as: Insulin-dependent diabetes mellitus (IDDM). Type 1 diabetes is the result of the body's failure to produce insulin, the hormone that allows glucose to enter the cells of the body to provide fuel. This is because of an auto-immune process in which the body's immune system attacks and destroys the insulin producing cells of the pancreas. - Stay healthy with a type 2 diabetes self management plan. By : John Richmond
Type 2 diabetes self management plans are critical in the control of diabetes which is a disease in which blood glucose levels are higher than normal. Those with diabetes have difficulty converting food into energy. After eating a meal, food is made into a sugar called glucose, and is then carried by the blood to the cells of the body. The cells use insulin, which is a hormone made in the pancreas, to aid in the conversion of glucose into energy. Type 2 diabetes is the result of the failure of the cells in the muscles, liver, and fat to use insulin properly. The pancreas then cannot produce sufficient insulin for the body's needs. This results in an increase in the amount of glucose in the blood while the cells are deprived of energy. Eventually, these high glucose levels cause damage to nerves and blood vessels, leading to complications. These include cardiovascular disease, stroke, kidney disease, blindness, nerve problems, and the amputation of limbs. - Are Surgeries A Solution For Diabetes? By : James Troy
It is said that for every 3 Americans born in the year 2000, 1 of them is likely to be contracted with diabetes during his lifetime. This means that by the year 2050, 29 million Americans will be diagnosed with diabetes, while another 10 million will have undiagnosed diabetes. This figure is estimated by The Center for Disease Control and Prevention. - Successful type 1 diabetes self management By : John Richmond
Type 1 diabetes is an autoimmune disease that destroys cells that produce insulin in the pancreas. When the body can no longer regulate blood sugar levels, daily injections of insulin are required to sustain life. While the cause of type 1 diabetes is not known, it is generally believed that environment and genetics play a key role. - Be informed about type 1 diabetes symptoms By : John Richmond
Initially, Type 1 diabetes symptoms may not signal danger. And, sometimes they appear quickly and threatening. Once started, they can progress rapidly over a span of weeks or a few months, and if action is take promptly they are usually diagnosed promptly. The most common type 1 diabetes symptoms seen are: - Medtronic Announces Alliance with LifeScan to Bring Leading Blood Glucose Meter to Its Diabetes By : Health News
Medtronic, Inc. (NYSE:MDT) today announced an exclusive United States agreement with LifeScan, Inc., a Johnson & Johnson (NYSE:JNJ) company, to distribute and co-market new blood glucose meters to be developed by LifeScan for Medtronic Diabetes patients. - What exactly is the cause of diabetes. By : John Richmond
The causes of diabetes are not totally known by medical science. There are still many questions about it that haven't been answered. Scientists are still at a loss as to why some people get it while others do not. It is known however, that having certain risk factors leads to diabetes. Some of these factors (lifestyle) are controllable while others (genetic) are not. - Share Your Experience Of Living With Type 2 Diabetes, UK By : Health News
The charity, Database of Personal Experience of health and illness (DIPEx), is looking for people to share their stories of living with Type 2 diabetes with others in a similar situation. - Major Research Project Needs You - Diabetes UK By : Health News
A new multi-million pound medical project needs thousands of volunteers from the UK to take part in one of the biggest and most detailed public health research initiatives of our time. - Hemoglobin A1c Levels Predict Risk Of Type 2 Diabetes In Middle-Aged, Older Women, Study Says By : Health News
Levels of hemoglobin A1c -- or HbA1c, a measure of blood sugar control -- in healthy middle-aged and older women can be an independent predictor of type 2 diabetes.............. - New Research May Lead To Oral Insulin, UK By : Health News
A significant step toward the development of oral insulin has been taken by researchers from the Robert Gordon University in Aberdeen, offering hope to diabetes patients who dread injections. - Long-term Rosiglitazone Use Linked To Raised Heart Attack And Heart Failure Risk By : Health News
Receiving rosiglitazone long-term raises the risk for heart failure and heart attack, according to a report in the Journal of the American Medical Association (JAMA). - Know the risk factors for type 2 diabetes By : John Richmond
Obesity. Being overweight is a leading risk factor for type 2 diabetes. The Body Mass Index (BMI) is the standard for determining body weight relative to health for most patients in the age group of 20 to 65 (excluding the highly conditioned such as athletes, or women who are nursing or pregnant.) A Body Mass Index in excess of 27 signals a risk for type 2 diabetes, and other complications such as heart disease, and early death. - Head To Head Clinical Trial Indicate Similar Safety Profile In Diabetic Patients For CYPHER® By : Health News
A subgroup analysis of diabetic patient data from a two-year randomized controlled trial comparing the CYPHER® Sirolimus-eluting Coronary Stent to the Taxus Stent showed no statistically significant differences in safety outcomes between the two drug-eluting stents.
|
